Clin Transpl 39(1):e70070
If you have concerns about continuing aspirin, discuss them with your GP or specialist
It gets there by combining appetite control from GLP-1, an insulin boost from GIP, and energy burning from glucagon
Proof of concept and mechanisms for DPP4-dependent glucose control in humans A crossover, placebo-controlled, clinical trial was undertaken in 93 patients with type 2 diabetes previously controlled with diet and exercise, baseline glycated hemoglobin (HbA1c) 7.4%, treated with 100 mg three times daily or 150 mg twice daily with the DPP4 inhibitor, 1-[[[2-[(5-cyanopyridin-2-yl)amino]eth-yl]amino]acetyl]-2-cyano-(S)-pyrrolidine (NVP DPP728) for 4 weeks
You really make it seem so easy with your presentation but I find this matter to be really something which I think I would never understand
But side effects are very under-reported. About half of adults who start GLP-1s stop within a year some because their insurance coverage changes with many reporting gastrointestinal side effects as a contributor